Abdulrahim A. Alzain, P., Elbadwi, F. A., & Alsamani, F. O. (2022). Discovery of novel TMPRSS2 inhibitors for COVID-19 using in silico fragment-based drug design, molecular docking, molecular dynamics, and quantum mechanics studies. Elsevier.

Abdulrahim A. Alzain, PhD, Fatima A. Elbadwi, and Fatima O. Alsamani. Discovery of Novel TMPRSS2 Inhibitors for COVID-19 Using in Silico Fragment-based Drug Design, Molecular Docking, Molecular Dynamics, and Quantum Mechanics Studies. Elsevier, 2022.

Abdulrahim A. Alzain, PhD, et al. Discovery of Novel TMPRSS2 Inhibitors for COVID-19 Using in Silico Fragment-based Drug Design, Molecular Docking, Molecular Dynamics, and Quantum Mechanics Studies. Elsevier, 2022.